AT320152B - Verfahren zur Herstellung von neuen Penicillinen - Google Patents

Verfahren zur Herstellung von neuen Penicillinen

Info

Publication number
AT320152B
AT320152B AT901072A AT901072A AT320152B AT 320152 B AT320152 B AT 320152B AT 901072 A AT901072 A AT 901072A AT 901072 A AT901072 A AT 901072A AT 320152 B AT320152 B AT 320152B
Authority
AT
Austria
Prior art keywords
production
new penicillins
penicillins
new
Prior art date
Application number
AT901072A
Other languages
German (de)
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of AT320152B publication Critical patent/AT320152B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06Anabolic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/38One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
AT901072A 1971-10-23 1972-10-20 Verfahren zur Herstellung von neuen Penicillinen AT320152B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2152967A DE2152967C3 (de) 1971-10-23 1971-10-23 Acylureidopenicilline

Publications (1)

Publication Number Publication Date
AT320152B true AT320152B (de) 1975-01-27

Family

ID=5823251

Family Applications (1)

Application Number Title Priority Date Filing Date
AT901072A AT320152B (de) 1971-10-23 1972-10-20 Verfahren zur Herstellung von neuen Penicillinen

Country Status (31)

Country Link
JP (2) JPS57843B2 (no)
AR (1) AR195805A1 (no)
AT (1) AT320152B (no)
BE (1) BE790440A (no)
BG (2) BG21609A3 (no)
CA (1) CA1019323A (no)
CH (1) CH579089A5 (no)
CS (1) CS188883B2 (no)
CY (1) CY947A (no)
DD (1) DD106044B3 (no)
DE (1) DE2152967C3 (no)
DK (1) DK134992C (no)
EG (1) EG10826A (no)
ES (1) ES407851A1 (no)
FI (1) FI56839C (no)
FR (1) FR2157908B1 (no)
GB (1) GB1392849A (no)
HK (1) HK18578A (no)
HU (1) HU167986B (no)
IE (1) IE37123B1 (no)
IL (1) IL40628A (no)
KE (1) KE2824A (no)
LU (1) LU66332A1 (no)
NO (1) NO143909C (no)
PH (1) PH9893A (no)
PL (2) PL93574B1 (no)
RO (2) RO60670A (no)
SE (1) SE412236B (no)
SU (1) SU527139A3 (no)
YU (1) YU264072A (no)
ZA (1) ZA727473B (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983105A (en) * 1971-10-23 1976-09-28 Bayer Aktiengesellschaft Penicillins
US4009272A (en) * 1971-10-23 1977-02-22 Bayer Aktiengesellschaft Penicillins
US3972869A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
US3974142A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
US3974141A (en) * 1971-10-23 1976-08-10 Bayer Aktiengesellschaft Penicillins
US3972870A (en) * 1971-10-23 1976-08-03 Bayer Aktiengesellschaft Penicillins
US3978056A (en) * 1971-10-23 1976-08-31 Bayer Aktiengesellschaft Penicillins
NL175419C (nl) * 1971-10-23 1984-11-01 Bayer Ag Werkwijze ter bereiding of vervaardiging van antibiotisch werkzame farmaceutische preparaten, alsmede werkwijze ter bereiding van antibiotisch werkzame alfa-gesubstitueerde 6-(alfa-(3-acylureido)acetylamino) penicillanzuurderivaten.
DE2258973A1 (de) * 1972-12-01 1974-06-06 Bayer Ag Penicilline, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS587637B2 (ja) * 1973-12-27 1983-02-10 住友化学工業株式会社 シンキペニシリンノ セイホウ
DE2407715C2 (de) * 1974-02-18 1982-12-02 Bayer Ag, 5090 Leverkusen Cephalosporine, Verfahren zu ihrer Herstellung sowie Arzneimittel
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
DE2525541C2 (de) * 1975-06-07 1984-01-12 Bayer Ag, 5090 Leverkusen β-Lactam-Antibiotica, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
DE2810083A1 (de) 1978-03-08 1979-09-20 Bayer Ag Beta-lactam-verbindungen
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
EP1780213A1 (en) * 2005-10-27 2007-05-02 3M Innovative Properties Company Silicon-urea-azolides, their preparation and use in the preparation of silicones with isocyanate terminal groups
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
NZ584145A (en) 2007-09-14 2012-03-30 Ortho Mcneil Janssen Pharm 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1,4'] bipyridinyl-2'-ones
EP2205565B1 (en) 2007-09-14 2013-04-17 Janssen Pharmaceuticals, Inc. 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones
EA019085B1 (ru) 2007-09-14 2014-01-30 Янссен Фармасьютикалз, Инк. 1',3-двузамещенные 4-(арил-х-фенил)-1н-пиридин-2-оны
MX2010005110A (es) 2007-11-14 2010-09-09 Ortho Mcneil Janssen Pharm Derivados de imidazo[1,2-a]piridina y su uso como moduladores alostericos positivos de los receptores de glutamato metabotropico 2.
ES2439291T3 (es) 2008-09-02 2014-01-22 Janssen Pharmaceuticals, Inc. Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos
US8697689B2 (en) 2008-10-16 2014-04-15 Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
MX2011005242A (es) 2008-11-28 2011-09-06 Ortho Mcneil Janssen Pharm Derivados de indol y benzoxazina como moduladores de los receptores de glutamato metabotropicos.
CA2760259C (en) 2009-05-12 2018-05-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MY161325A (en) 2009-05-12 2017-04-14 Janssen Pharmaceuticals Inc 1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JP5916129B2 (ja) * 2009-06-10 2016-05-11 テックフィールズ バイオケム カンパニー リミテッド 抗菌薬および抗菌薬関連化合物の高透過性組成物またはプロドラッグ
ES2536433T3 (es) 2010-11-08 2015-05-25 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
JP5852664B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド 1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
CN103298809B (zh) 2010-11-08 2016-08-31 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
WO2015110435A1 (en) 2014-01-21 2015-07-30 Janssen Pharmaceutica Nv Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
ME03518B (me) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1770620A1 (de) * 1968-06-12 1971-11-11 Bayer Ag Neue Penicilline

Also Published As

Publication number Publication date
GB1392849A (en) 1975-04-30
KE2824A (en) 1978-04-07
IL40628A (en) 1976-08-31
FI56839C (fi) 1980-04-10
DK134992C (da) 1977-07-18
DE2152967A1 (de) 1973-05-03
JPS4849910A (no) 1973-07-14
JPS4849787A (no) 1973-07-13
RO60670A (no) 1976-10-15
DK134992B (da) 1977-02-21
IE37123L (en) 1973-04-23
SU527139A3 (ru) 1976-08-30
CY947A (en) 1978-06-23
IE37123B1 (en) 1977-05-11
YU264072A (en) 1982-06-18
AU4806472A (en) 1974-04-26
NO143909C (no) 1981-05-06
IL40628A0 (en) 1972-12-29
CS188883B2 (en) 1979-03-30
BE790440A (no) 1973-04-24
DE2152967B2 (de) 1981-02-19
CA1019323A (en) 1977-10-18
PH9893A (en) 1976-06-08
ZA727473B (en) 1973-07-25
JPS55391B2 (no) 1980-01-08
PL89056B1 (no) 1976-10-30
PL93574B1 (no) 1977-06-30
FR2157908A1 (no) 1973-06-08
DE2152967C3 (de) 1981-11-19
LU66332A1 (no) 1973-01-23
NO143909B (no) 1981-01-26
JPS57843B2 (no) 1982-01-08
HK18578A (en) 1978-04-14
CH579089A5 (no) 1976-08-31
AR195805A1 (es) 1973-11-09
FI56839B (fi) 1979-12-31
HU167986B (no) 1976-02-28
SE412236B (sv) 1980-02-25
DD106044B3 (de) 1990-07-18
DD106044A5 (no) 1974-05-20
BG20813A3 (bg) 1975-12-20
EG10826A (en) 1976-12-31
FR2157908B1 (no) 1976-03-19
BG21609A3 (bg) 1976-07-20
RO63066A (fr) 1978-06-15
ES407851A1 (es) 1975-10-01

Similar Documents

Publication Publication Date Title
AT320152B (de) Verfahren zur Herstellung von neuen Penicillinen
AT320637B (de) Verfahren zur Herstellung von neuen Imidazolderivaten
AT321462B (de) Verfahren zur Herstellung von neuen Penicillinen
AT318804B (de) Verfahren zur Herstellung von neuen 3-Methylencephalosporinen
AT314555B (de) Verfahren zur Herstellung von neuen Guanidinen
AT321460B (de) Verfahren zur Herstellung von Cephalosporinen
AT287198B (de) Verfahren zur Herstellung von neuen Penicillinen
AT308764B (de) Verfahren zur Herstellung von neuen N-Phosphonomethyl-acrylamiden
AT318140B (de) Verfahren zur Herstellung von neuen Penicillinen
AT327376B (de) Verfahren zur herstellung von neuen 7-acylamido-7-methoxy-cephemcarbonsaurederivaten
AT327377B (de) Verfahren zur herstellung von aminopenicillinen
CH553801A (de) Verfahren zur herstellung von neuen diazepinderivaten.
AT309683B (de) Verfahren zur Herstellung von neuen Penicillinen
AT323325B (de) Verfahren zur herstellung von neuen 3-oxyiminomethylcephalosporinverbindungen
AT312804B (de) Verfahren zur Herstellung von neuen Penicillinen
AT310187B (de) Verfahren zur Herstellung von neuen Phosphorverbindungen
AT289296B (de) Verfahren zur Herstellung von neuen Penicillinen
AT313299B (de) Verfahren zur Herstellung von neuen 2-Fluor-5-halogenphenylharnstoffen
AT323184B (de) Verfahren zur herstellung von neuen dibenzoxirenazepinderivaten
AT313915B (de) Verfahren zur Herstellung von neuen Guanidinomercaptocarbonsäuren
AT297223B (de) Verfahren zur Herstellung von neuen Penicillinen
AT329517B (de) Verfahren zur herstellung von chlorcyan
AT322736B (de) Verfahren zur herstellung von 3-carbomoyloxymethyl-cephalosporinen
AT296498B (de) Verfahren zur Herstellung von neuen Penicillinen
AT326269B (de) Verfahren zur herstellung von neuen halogenphenylthioacetamido-cephalosporinderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee